570 filings
Page 6 of 29
6-K
MOR
Morphosys AG
21 Dec 23
Current report (foreign)
10:19am
6-K
MOR
Morphosys AG
19 Dec 23
Current report (foreign)
10:08am
6-K
MOR
Morphosys AG
18 Dec 23
Current report (foreign)
10:28am
6-K
MOR
Morphosys AG
14 Dec 23
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014
12:29pm
6-K
MOR
Morphosys AG
13 Dec 23
Current report (foreign)
10:11am
6-K
MOR
Morphosys AG
11 Dec 23
Current report (foreign)
11:39am
6-K
MOR
Morphosys AG
11 Dec 23
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
11:26am
6-K
MOR
Morphosys AG
7 Dec 23
Current report (foreign)
10:13am
6-K
MOR
Morphosys AG
6 Dec 23
Current report (foreign)
10:44am
6-K
MOR
Morphosys AG
5 Dec 23
Current report (foreign)
10:13am
6-K
MOR
Morphosys AG
4 Dec 23
Current report (foreign)
10:06am
6-K
MOR
Morphosys AG
1 Dec 23
Current report (foreign)
10:23am
6-K
MOR
Morphosys AG
30 Nov 23
Current report (foreign)
11:19am
6-K
MOR
Morphosys AG
29 Nov 23
Current report (foreign)
10:26am
6-K
MOR
Morphosys AG
27 Nov 23
Current report (foreign)
10:14am
6-K
MOR
Morphosys AG
24 Nov 23
Current report (foreign)
6:04am
6-K
MOR
Morphosys AG
22 Nov 23
Current report (foreign)
10:41am
6-K
MOR
Morphosys AG
21 Nov 23
Topline Results Phase 3 MANIFEST-2 Study Pelabresib in First-Line Myelofibrosis November 2023 Gail, Living with Myelofibrosis since 2018
10:08am
6-K
MOR
Morphosys AG
20 Nov 23
Current report (foreign)
4:55pm
6-K
MOR
Morphosys AG
20 Nov 23
Current report (foreign)
10:06am